A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
Retinal Imaging in Neurodegenerative Disease
- Status
- RECRUITING
- Phase
- N/A
Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Wake Forest Alzheimer's Disease Clinical Core
- Status
- RECRUITING
- Phase
- N/A
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
- Status
- TERMINATED
- Phase
- PHASE3
Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients
- Status
- COMPLETED
- Phase
- PHASE1
Z-Drugs for Sleep Disorders in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Nicotinamide as an Early Alzheimer's Disease Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- Status
- RECRUITING
- Phase
- N/A
Auditory Rehabilitation and Cognition in Alzheimer Patients
- Status
- COMPLETED
- Phase
- NA
A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia
- Status
- TERMINATED
- Phase
- PHASE3
Alzheimer's Disease and Physiological, Cognitive Function and BDNF Levels of Plasma Adaptation After Exercise Training
- Status
- COMPLETED
- Phase
- NA
Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration
- Status
- COMPLETED
- Phase
- N/A
A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE3
Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Visuospatial Attention, Eye Movements and Instrumental Activities of Daily Living (IADLs) in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- NA
Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations
- Status
- UNKNOWN
- Phase
- PHASE1
Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2